Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms 18F-FC-119(S), 18F-FC-119S, Alzavue |
Target |
Action modulators |
Mechanism APP modulators(Beta amyloid A4 protein modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC16H16FN3O2S |
InChIKeyUUTHBXIFQOWLKI-RLNGUBADSA-N |
CAS Registry1383958-91-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Alzheimer Disease | - | - |
Not Applicable | - | F-18 Florapronol (FPN) PET | kdobmzehxz(kplidjuheg) = udbaeipboy fcymzsozvr (uhmmtcysmc ) View more | - | 09 Jun 2024 | ||
Not Applicable | - | F-18 Florapronol (Amyloid-positive) | hzvhldwbfi(xridgzqiir) = pyvijllvdj esezekyngd (ucpynaynlb ) | - | 09 Jun 2024 | ||
F-18 Florapronol (Amyloid-negative) | hzvhldwbfi(xridgzqiir) = yoswzomijt esezekyngd (ucpynaynlb ) |